Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005199
Filing Date
2016-05-03
Accepted
2016-05-03 16:22:40
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20160331x10q.htm 10-Q 1259861
2 EX-10.1 rigl-20160331ex101a971fb.htm EX-10.1 870107
3 EX-31.1 rigl-20160331ex311ac7efa.htm EX-31.1 17858
4 EX-31.2 rigl-20160331ex312d356d2.htm EX-31.2 17880
5 EX-32.1 rigl-20160331ex32101bc45.htm EX-32.1 9282
  Complete submission text file 0001558370-16-005199.txt   5191420

Data Files

Seq Description Document Type Size
6 EX-101.INS rigl-20160331.xml EX-101.INS 889401
7 EX-101.SCH rigl-20160331.xsd EX-101.SCH 35538
8 EX-101.CAL rigl-20160331_cal.xml EX-101.CAL 34871
9 EX-101.DEF rigl-20160331_def.xml EX-101.DEF 98759
10 EX-101.LAB rigl-20160331_lab.xml EX-101.LAB 280410
11 EX-101.PRE rigl-20160331_pre.xml EX-101.PRE 199443
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 161615753
SIC: 2834 Pharmaceutical Preparations